How would you treat lung adenocarcinoma patients progressing on osimertinib who are not candidates for chemotherapy?

First, I will point out that there are a number of other questions that have come up that touch on this question which I have referenced below. This is certainly a challenging scenario. Obviously, if a patient is not a candidate for chemotherapy, they are likely not a candidate for a clinical trial,...